Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous…
GlobalData estimates the drug to earn $3.12 billion by 2029
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.